CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
Calcium Channel Blocker & Adenosinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00413712
NCT00413712Phase 4Completed
CompareCT.gov

Comparism Between Efficacy and Effectiveness Between Slow Infusion of Calcium Channel Blockers and Intravenous Bolus Adenosine in the Management of Supraventricular Tachycardia in the Emergency Department.

Singapore General Hospital·interventional·Posted Dec 20, 2006·Updated Feb 10, 2017

In Brief

A Phase 4 clinical trial evaluating Calcium Channel Blocker & Adenosine for Supraventricular Tachycardia. Completed, across 1 site.

Detailed Summary

The purpose of this study is to determine the efficacy and effectiveness of calcium channel blockers and adenosine in the treatment of Supraventricular Tachycardia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSupraventricular Tachycardia
CountriesSingapore
Collaborators--

Timeline

Phase 4CompletedFinished
1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 20, 2006
Enrollment StartJan 1, 1997
Study CompletionMar 1, 2001
TodayJul 2, 2026
Posted 19.5 years ago

Interventions

Calcium Channel Blocker & Adenosinedrug